Receptores de dopamina y heterómeros de receptores de dopamina en la modulación de la neurotransmisión [PDF]
, 2012 [spa] La mayoría de los ligandos de GPCR que actúan como agonistas, antagonistas o agonistas inversos, se unen al mismo dominio del receptor reconocido por los agonistas endógenos, es decir, el lugar de unión ortostérico.
González González, Sergio
core +6 more sources
Does Intravitreal Dopamine Agonist and Antagonist Administration Have Effects on the Brain? An Experimental Study in Rats. [PDF]
Eurasian J Med, 2022 Objective: There might be dopaminergic connections between the retina and the brain. In this context, the study was aimed to investigate the possible interaction between the retina and basal ganglia through the dopaminergic system. Materials and Methods:
Kocak MN +6 more
europepmc +2 more sources
Incidental Resolution of Dopamine Agonist Induced Impulse Control Disorder with GLP-1 Receptor Agonist. [PDF]
Mov Disord Clin PractMovement Disorders Clinical Practice, EarlyView.
Kelly H, Davis T.
europepmc +2 more sources
The effects of the dopamine agonist rotigotine on hemispatial neglect following stroke [PDF]
, 2012 Hemispatial neglect following right-hemisphere stroke is a common and disabling disorder, for which there is currently no effective pharmacological treatment. Dopamine agonists have been shown to play a role in selective attention and working memory, two
Kulinskaya, Elena +26 more
core +1 more source
Heterómeros de receptores de dopamina. Nuevos mecanismos para la regulación de la transmisión dopaminérgica [PDF]
, 2012 [spa] El Objetivo General de esta Tesis ha sido investigar la formación y función de heterómeros entre receptores de dopamina y otros receptores que puedan estar implicados en la regulación de la transmisión dopaminérgica, como receptores de galanina ...
Moreno Guillén, Estefanía
core +6 more sources
D1 receptor agonist improves sleep–wake parameters in experimental parkinsonism
Neurobiology of Disease, 2014 Both excessive daytime sleepiness (EDS) and rapid eye movement (REM) sleep deregulation are part of Parkinson's disease (PD) non-motor symptoms and may complicate dopamine replacement therapy.
Carole Hyacinthe +4 more
doaj +1 more source
Journal of Parkinson’s Disease, 2013 Background: Dopamine agonist therapy is the main risk factor for impulse control disorders in Parkinson's disease (PD). However, it is unclear whether bilateral deep brain stimulation of the subthalamic nucleus also causes impairment in decision making ...
Atbin Djamshidian +8 more
doaj +1 more source
Dopaminergic activation of estrogen receptors induces fos expression within restricted regions of the neonatal female rat brain. [PDF]
PLoS ONE, 2008 Steroid receptor activation in the developing brain influences a variety of cellular processes that endure into adulthood, altering both behavior and physiology.
Kristin M Olesen, Anthony P Auger
doaj +1 more source
Dopamine genetic risk score predicts impulse control behaviors in Parkinson’s disease
Clinical Parkinsonism & Related Disorders, 2021 Introduction: Up to 40% of Parkinson’s disease patients taking dopamine agonist medication develop impulse control behaviors which can have severe negative consequences.
Alison Hall +5 more
doaj +1 more source
An investigation into the function of single-neuron activity in the mesoaccumbens dopamine system of the rat [PDF]
, 2012 The mesoaccumbens dopamine system has been implicated in many basic psychological processes (e.g. "wanting" and "liking") and illnesses (e.g. addiction, depression, schizophrenia).
Wilson, David Ian Greig
core +2 more sources